Acute Pancreatitis in Association With Type 2 Diabetes and Antidiabetic Drugs A population-based cohort study

被引:142
作者
Gonzalez-Perez, Antonio [1 ,2 ]
Schlienger, Raymond G. [3 ]
Garcia Rodriguez, Luis A. [1 ]
机构
[1] Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain
[2] Neocodex SL, Dept Genom Estruct, Seville, Spain
[3] Novartis Pharma AG, Global Clin Epidemiol, Basel, Switzerland
关键词
IMPROVEMENT NETWORK THIN; RISK; DEPRIVATION; METFORMIN; EPIDEMIOLOGY; ETIOLOGY;
D O I
10.2337/dc10-0842
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
OBJECTIVE - Previous observational studies have found an increased risk of acute pancreatitis among type 2 diabetic patients However limited information is available on this association and specifically on the role of antidiabetic treatment Our aim therefore was to further assess the risk of acute pancreatitis in adult patients with type 2 diabetes RESEARCH DESIGN AND METHODS - We performed a population-based case-control analysis nested in a cohort of 85 525 type 2 diabetic patients and 200 000 diabetes-free individuals from the general population using data from The Health Improvement Network database Subjects were followed up to ascertain incident cases of acute pancreatitis RESULTS - We identified 419 cases of acute pancreatitis 243 in the general population and 176 in the diabetes cohort Incidence rates were 30 1 and 54 0 per 100 000 person-years in the general population and the diabetes cohort respectively In the cohort analysis the adjusted incidence rate ratio of acute pancreatitis in diabetic patients versus that in the general population was 1 77 (95% CI 1 46-2 15) The magnitude of this association decreased with adjustment for multiple factors in the nested case-control analysis (adjusted odds ratio 1 37 [95% CI 0 99-1 89]) Furthermore we found that the risk of acute pancreatitis was decreased among insulin-treated diabetic patients (0 35 [0 20-0 61]) CONCLUSIONS - Type 2 diabetes may be associated with a slight increase in the risk of acute pancreatitis We also found that insulin use in type 2 diabetes might decrease this risk Further research is warranted to confirm these associations
引用
收藏
页码:2580 / 2585
页数:6
相关论文
共 19 条
[1]
Drug-induced acute pancreatitis: An evidence-based review [J].
Badalov, Nison ;
Baradarian, Robin ;
Iswara, Kadirawel ;
Li, Jianjun ;
Steinberg, William ;
Tenner, Scott .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (06) :648-661
[2]
Drug-Induced Pancreatitis Incidence, Management and Prevention [J].
Balani, Anil R. ;
Grendell, James H. .
DRUG SAFETY, 2008, 31 (10) :823-837
[3]
Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis [J].
Blomgren, KB ;
Sundström, A ;
Steineck, G ;
Wiholm, BE .
DIABETES CARE, 2002, 25 (02) :298-302
[4]
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide [J].
Dore, David D. ;
Seeger, John D. ;
Chan, K. Arnold .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) :1019-1027
[5]
Eland IA, 2000, SCAND J GASTROENTERO, V35, P1110
[6]
Incidence of acute pancreatitis [J].
Eland, IA ;
Sturkenboom, MCJM ;
van der Lei, J ;
Wilson, JHP ;
Stricker, BHC ;
Stricker, BHC .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (01) :124-124
[7]
Antihypertensive medication and the risk of acute pancreatitis:: The European case-control study on drug-induced acute pancreatitis (EDIP) [J].
Eland, Ingo A. ;
Sundström, Anders ;
Velo, Giancarlo P. ;
Andersen, Morten ;
Sturkenboom, Miriam C. J. M. ;
Langman, Michael J. S. ;
Stricker, Bruno H. Ch. ;
Beje, Wiholm .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2006, 41 (12) :1484-1490
[8]
Metformin-induced pancreatitis - A possible adverse drug effect during acute renal failure [J].
Fimognari, FL ;
Corsonello, A ;
Pastorell, R ;
Antonelli-Incalzi, R .
DIABETES CARE, 2006, 29 (05) :1183-1183
[9]
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research [J].
Lewis, James D. ;
Schinnar, Rita ;
Bilker, Warren B. ;
Wang, Xingmei ;
Strom, Brian L. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (04) :393-401
[10]
Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection [J].
Lo Re, Vincent, III ;
Haynes, Kevin ;
Forde, Kimberly A. ;
Localio, A. Russell ;
Schinnar, Rita ;
Lewis, James D. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (09) :807-814